Go Pro

SmileDirectClub (SDCCQ) Competitors

SDCCQ vs. GMVDF, VRAYQ, TTOO, AFIB, and UTRS

Should you buy SmileDirectClub stock or one of its competitors? MarketBeat compares SmileDirectClub with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with SmileDirectClub include G Medical Innovations (GMVDF), ViewRay (VRAYQ), T2 Biosystems (TTOO), Acutus Medical (AFIB), and Minerva Surgical (UTRS). These companies are all part of the "medical equipment" industry.

How does SmileDirectClub compare to G Medical Innovations?

G Medical Innovations (NASDAQ:GMVDF) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, institutional ownership, profitability, dividends, valuation, analyst recommendations, earnings and media sentiment.

6.0% of G Medical Innovations shares are held by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are held by institutional investors. 37.1% of G Medical Innovations shares are held by company insiders. Comparatively, 64.7% of SmileDirectClub shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

G Medical Innovations has a beta of 27.28, suggesting that its stock price is 2,628% more volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.35, suggesting that its stock price is 35% more volatile than the broader market.

In the previous week, G Medical Innovations' average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company Overall Sentiment
G Medical Innovations Neutral
SmileDirectClub Neutral

Company Net Margins Return on Equity Return on Assets
G Medical InnovationsN/A N/A N/A
SmileDirectClub N/A N/A N/A

G Medical Innovations has higher earnings, but lower revenue than SmileDirectClub.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
G Medical Innovations$4.42M0.00-$24.63MN/AN/A
SmileDirectClub$470.74M0.00-$86.40M-$0.29N/A

Summary

G Medical Innovations beats SmileDirectClub on 3 of the 5 factors compared between the two stocks.

How does SmileDirectClub compare to ViewRay?

SmileDirectClub (NASDAQ:SDCCQ) and ViewRay (NASDAQ:VRAYQ) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment.

SmileDirectClub has a beta of 1.35, indicating that its stock price is 35% more volatile than the broader market. Comparatively, ViewRay has a beta of 0.9, indicating that its stock price is 10% less volatile than the broader market.

0.1% of SmileDirectClub shares are owned by institutional investors. Comparatively, 15.5% of ViewRay shares are owned by institutional investors. 64.7% of SmileDirectClub shares are owned by insiders. Comparatively, 2.5% of ViewRay shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

SmileDirectClub has higher revenue and earnings than ViewRay.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SmileDirectClub$470.74M0.00-$86.40M-$0.29N/A
ViewRay$102.21M0.00-$107.33M-$0.31N/A

In the previous week, ViewRay had 1 more articles in the media than SmileDirectClub. MarketBeat recorded 1 mentions for ViewRay and 0 mentions for SmileDirectClub. SmileDirectClub's average media sentiment score of 0.00 equaled ViewRay'saverage media sentiment score.

Company Overall Sentiment
SmileDirectClub Neutral
ViewRay Neutral

Company Net Margins Return on Equity Return on Assets
SmileDirectClubN/A N/A N/A
ViewRay N/A N/A N/A

Summary

SmileDirectClub beats ViewRay on 5 of the 8 factors compared between the two stocks.

How does SmileDirectClub compare to T2 Biosystems?

SmileDirectClub (NASDAQ:SDCCQ) and T2 Biosystems (NASDAQ:TTOO) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, media sentiment, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings.

SmileDirectClub has a beta of 1.35, suggesting that its stock price is 35% more volatile than the broader market. Comparatively, T2 Biosystems has a beta of 7.71, suggesting that its stock price is 671% more volatile than the broader market.

0.1% of SmileDirectClub shares are owned by institutional investors. Comparatively, 23.2% of T2 Biosystems shares are owned by institutional investors. 64.7% of SmileDirectClub shares are owned by company insiders. Comparatively, 0.0% of T2 Biosystems shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled T2 Biosystems'average media sentiment score.

Company Overall Sentiment
SmileDirectClub Neutral
T2 Biosystems Neutral

T2 Biosystems has lower revenue, but higher earnings than SmileDirectClub. T2 Biosystems is trading at a lower price-to-earnings ratio than SmileDirectClub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SmileDirectClub$470.74M0.00-$86.40M-$0.29N/A
T2 Biosystems$7.68M0.01-$50.08M-$3.89N/A

SmileDirectClub has a net margin of 0.00% compared to T2 Biosystems' net margin of -563.16%.

Company Net Margins Return on Equity Return on Assets
SmileDirectClubN/A N/A N/A
T2 Biosystems -563.16%N/A -174.06%

Summary

SmileDirectClub beats T2 Biosystems on 6 of the 9 factors compared between the two stocks.

How does SmileDirectClub compare to Acutus Medical?

Acutus Medical (NASDAQ:AFIB) and SmileDirectClub (NASDAQ:SDCCQ) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership and profitability.

In the previous week, Acutus Medical's average media sentiment score of 0.00 equaled SmileDirectClub'saverage media sentiment score.

Company Overall Sentiment
Acutus Medical Neutral
SmileDirectClub Neutral

Acutus Medical has a beta of 5.67, suggesting that its stock price is 467% more volatile than the broader market. Comparatively, SmileDirectClub has a beta of 1.35, suggesting that its stock price is 35% more volatile than the broader market.

SmileDirectClub has a net margin of 0.00% compared to Acutus Medical's net margin of -272.74%. SmileDirectClub's return on equity of 0.00% beat Acutus Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Acutus Medical-272.74% -311.64% -11.57%
SmileDirectClub N/A N/A N/A

56.9% of Acutus Medical shares are held by institutional investors. Comparatively, 0.1% of SmileDirectClub shares are held by institutional investors. 5.2% of Acutus Medical shares are held by insiders. Comparatively, 64.7% of SmileDirectClub shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Acutus Medical has higher earnings, but lower revenue than SmileDirectClub. Acutus Medical is trading at a lower price-to-earnings ratio than SmileDirectClub, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Acutus Medical$7.16M0.00-$81.66M-$0.11N/A
SmileDirectClub$470.74M0.00-$86.40M-$0.29N/A

Summary

SmileDirectClub beats Acutus Medical on 6 of the 10 factors compared between the two stocks.

How does SmileDirectClub compare to Minerva Surgical?

SmileDirectClub (NASDAQ:SDCCQ) and Minerva Surgical (NASDAQ:UTRS) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, profitability, risk, analyst recommendations, dividends, valuation and institutional ownership.

Company Net Margins Return on Equity Return on Assets
SmileDirectClubN/A N/A N/A
Minerva Surgical N/A N/A N/A

0.1% of SmileDirectClub shares are held by institutional investors. 64.7% of SmileDirectClub shares are held by insiders. Comparatively, 8.5% of Minerva Surgical shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Minerva Surgical has lower revenue, but higher earnings than SmileDirectClub.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
SmileDirectClub$470.74M0.00-$86.40M-$0.29N/A
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A

SmileDirectClub has a beta of 1.35, suggesting that its stock price is 35% more volatile than the broader market. Comparatively, Minerva Surgical has a beta of 2.92, suggesting that its stock price is 192% more volatile than the broader market.

In the previous week, SmileDirectClub's average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company Overall Sentiment
SmileDirectClub Neutral
Minerva Surgical Neutral

Summary

SmileDirectClub beats Minerva Surgical on 4 of the 7 factors compared between the two stocks.

Get SmileDirectClub News Delivered to You Automatically

Sign up to receive the latest news and ratings for SDCCQ and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SDCCQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SDCCQ vs. The Competition

MetricSmileDirectClubDental equipment & supplies IndustryMedical SectorNASDAQ Exchange
Market Cap$40K$2.87M$7.16B$12.48B
Dividend YieldN/AN/A2.66%6.52%
P/E Ratio0.00N/A28.0224.70
Price / SalesN/A0.06540.3799.49
Price / CashN/AN/A49.2657.09
Price / BookN/A0.0110.966.46
Net Income-$86.40M-$60.92M$3.57B$337.01M

SmileDirectClub Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SDCCQ
SmileDirectClub
N/AN/AN/AN/A$40K$470.74MN/A2,700
GMVDF
G Medical Innovations
N/AN/AN/AN/A$26K$4.42MN/A72
VRAYQ
ViewRay
N/AN/AN/AN/A$18K$102.21MN/A300
TTOO
T2 Biosystems
N/A$0.00
flat
N/A-98.6%$11K$7.68MN/A180
AFIB
Acutus Medical
N/AN/AN/AN/A$3K$7.16MN/A340

Related Companies and Tools


This page (NASDAQ:SDCCQ) was last updated on 7/5/2026 by MarketBeat.com Staff.
From Our Partners